Enhancing ENCODE Through a Transcription Factor Tagging Approach to ChIP-seq

通过 ChIP-seq 的转录因子标记方法增强 ENCODE

基本信息

  • 批准号:
    8327886
  • 负责人:
  • 金额:
    $ 89.24万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-30 至 2012-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): We propose to use bacterial artificial chromosome (BAC) recombineering to epitope tag 40 transcription factors per year for chromatin immunoprecipitation (ChIP) followed by sequencing to map binding sites genome wide. A major hurdle for the ENCODE project is the availability of ChIP-grade antibodies for each factor to be analyzed. Epitope tagging of chromatin-associated proteins presents an alternative approach for ChIP, using the same epitope-specific antibody for each factor. Expressing epitope tagged factors from BACs ensures that the factors are expressed at near-physiological levels due to the presence of endogenous regulatory sequences that drive each tagged factor from its native local genomic context. We propose to analyze a diversity of transcription factors using this method, which we have already demonstrated for more than 20 nuclear receptor class proteins, a forkhead domain protein, Jun and Fos, and several other types of factors (Poser et al. 2008; Hua, Kittler and White 2009). The goal of this project is to integrate our approach with the ENCODE project, testing it for a wider diversity of transcription and chromatin-associated factors and scaling the approach to production levels necessary for ENCODE. The proposed project involves a formal collaboration between the White and Snyder labs, as well as integration with other funded ENCODE and human epigenome projects. PUBLIC HEALTH RELEVANCE: Using a BAC recombineering approach, we propose to systematically epitope tag transcription and chromatin associated factors for ChIP-seq to speed current large-scale mapping projects such as the Encyclopedia of DNA Elements (ENCODE) project by eliminating the laborious step of antibody production and testing. The technology presented here has the potential to facilitate the large-scale identification of the binding sites of mammalian transcription factors and other chromatin-binding proteins. This technology will also enable the ChIP analysis of proteins that are recalcitrant to ChIP grade antibody production and thus impractical to map using the conventional factor-specific antibody ChIP approach for mammalian cells.
描述(由申请人提供):我们建议每年使用细菌人工染色体(BAC)重组工程来标记40个转录因子的表位,用于染色质免疫沉淀(ChIP),然后测序以在全基因组范围内定位结合位点。ENCODE项目的一个主要障碍是要分析的每个因素的ChIP级抗体的可用性。染色质相关蛋白的表位标记为ChIP提供了一种替代方法,对每个因子使用相同的表位特异性抗体。从BAC表达表位标记的因子确保了因子以接近生理水平表达,这是由于存在内源性调节序列,所述内源性调节序列驱动每个标记的因子脱离其天然局部基因组环境。我们建议使用这种方法分析多种转录因子,我们已经证明了超过20种核受体类蛋白、叉头结构域蛋白、Jun和Fos以及其他几种类型的因子(Poser et al. 2008; Hua,Kittler and白色2009)。该项目的目标是将我们的方法与ENCODE项目相结合,测试其更广泛的转录和染色质相关因子的多样性,并将该方法扩展到ENCODE所需的生产水平。拟议的项目涉及白色和斯奈德实验室之间的正式合作,以及与其他资助的ENCODE和人类表观基因组项目的整合。 公共卫生关系:使用BAC重组工程方法,我们建议系统地为ChIP-seq标记表位标签转录和染色质相关因子,以通过消除抗体生产和测试的费力步骤来加速当前的大规模作图项目,例如DNA元件百科全书(ENCODE)项目。这里提出的技术有可能促进哺乳动物转录因子和其他染色质结合蛋白的结合位点的大规模鉴定。该技术还将使得能够对与ChIP级抗体生产无关的蛋白质进行ChIP分析,因此使用常规因子特异性抗体ChIP方法对哺乳动物细胞进行作图是不切实际的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KEVIN P. WHITE其他文献

KEVIN P. WHITE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KEVIN P. WHITE', 18)}}的其他基金

Center for Functional Validation and Evaluation of ENCODE Enhancer Regions, Grant Number 5UM1HG009426-03
ENCODE 增强区域功能验证和评估中心,授权号 5UM1HG009426-03
  • 批准号:
    10049145
  • 财政年份:
    2019
  • 资助金额:
    $ 89.24万
  • 项目类别:
Micro-western array methodology for assessment of preanalytical variability in bi
用于评估双组分分析前变异性的微西方阵列方法
  • 批准号:
    8848052
  • 财政年份:
    2014
  • 资助金额:
    $ 89.24万
  • 项目类别:
Custom-built Digital Scanned Laser Light Sheet Microscope (DSLM)
定制数字扫描激光光片显微镜 (DSLM)
  • 批准号:
    8247214
  • 财政年份:
    2012
  • 资助金额:
    $ 89.24万
  • 项目类别:
Experimental genomics and phenotyping: to produce new data & verify predictions
实验基因组学和表型分析:产生新数据
  • 批准号:
    8936052
  • 财政年份:
    2011
  • 资助金额:
    $ 89.24万
  • 项目类别:
Experimental genomics and phenotyping: to produce new data & verify predictions
实验基因组学和表型分析:产生新数据
  • 批准号:
    8935558
  • 财政年份:
    2011
  • 资助金额:
    $ 89.24万
  • 项目类别:
Experimental genomics and phenotyping: to produce new data & verify predictions
实验基因组学和表型分析:产生新数据
  • 批准号:
    8382708
  • 财政年份:
    2011
  • 资助金额:
    $ 89.24万
  • 项目类别:
Illumina Genome AnalyzerII (GAII) (110v/220v)
Illumina 基因组分析仪 II (GAII) (110v/220v)
  • 批准号:
    7794393
  • 财政年份:
    2010
  • 资助金额:
    $ 89.24万
  • 项目类别:
Enhancing ENCODE Through a Transcription Factor Tagging Approach to ChIP-seq
通过 ChIP-seq 的转录因子标记方法增强 ENCODE
  • 批准号:
    7853780
  • 财政年份:
    2009
  • 资助金额:
    $ 89.24万
  • 项目类别:
Enhancing ENCODE Through a Transcription Factor Tagging Approach to ChIP-seq
通过 ChIP-seq 的转录因子标记方法增强 ENCODE
  • 批准号:
    7943991
  • 财政年份:
    2009
  • 资助金额:
    $ 89.24万
  • 项目类别:
A Cis Regulatory map of the Drosophila Genome
果蝇基因组的顺式调控图
  • 批准号:
    7925013
  • 财政年份:
    2009
  • 资助金额:
    $ 89.24万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 89.24万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 89.24万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 89.24万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 89.24万
  • 项目类别:
    Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 89.24万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 89.24万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 89.24万
  • 项目类别:
    Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
  • 批准号:
    10699504
  • 财政年份:
    2023
  • 资助金额:
    $ 89.24万
  • 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
  • 批准号:
    10491642
  • 财政年份:
    2023
  • 资助金额:
    $ 89.24万
  • 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
  • 批准号:
    10782567
  • 财政年份:
    2023
  • 资助金额:
    $ 89.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了